OPGN Insider Trading (OpGen)
Insider Ownership Percentage: 1.26%
Insider Buying (Last 12 Months): $51,600.00
Insider Selling (Last 12 Months): $0.00
OpGen Share Price & Price History
Current Price: $0.57
Price Change: ▲ Price Increase of +0.0266 (4.88%)
As of 07/1/2022 06:44 PM ET
27 U.S. Cities Where Stocks Yield 26% a Year
From Investing Daily | Ad
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!
When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.
Get in on the action here.
OpGen Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 1/26/2022 | Johannes Bacher | COO | Buy | 25,000 | $0.85 | $21,250.00 | |  |
| 11/18/2021 | Oliver Schacht | CEO | Buy | 10,000 | $1.50 | $15,000.00 | | |
| 9/15/2021 | Johannes Bacher | COO | Buy | 5,000 | $3.07 | $15,350.00 | 25,000 | |
| 10/27/2020 | Evan/ Fa Jones | Director | Sell | 1,748 | $2.35 | $4,107.80 | | |
| 9/4/2020 | Evan/ Fa Jones | Director | Sell | 3,612 | $2.19 | $7,910.28 | | |
| 4/22/2020 | N.V. In Liquidation Curetis | Major Shareholder | Sell | 42,375 | $2.24 | $94,920.00 | 1,669,180 | |
| 4/20/2020 | N.V. In Liquidation Curetis | Major Shareholder | Sell | 55,142 | $2.35 | $129,583.70 | 1,862,306 | |
| 4/17/2020 | N.V. In Liquidation Curetis | Major Shareholder | Sell | 165,902 | $2.46 | $408,118.92 | 1,862,306 | |
Tailor an Options Trading Strategy to Fit Your Needs
From RJO Futures | Ad
This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.
Take your trading to the next level with the Options Strategy Guide.
Download your FREE Options Strategy Guide Today.
OpGen Institutional Trading History
| Reporting Date | Hedge Fund | Shares Held | Market Value | % of Portfolio | Quarterly Change in Shares | Ownership in Company | Details |
|---|
| 5/13/2022 | Renaissance Technologies LLC | 1,131,756 | $0.85M | 0.0% | -33.3% | 2.431% |  |
| 5/13/2022 | Vanguard Group Inc. | 1,342,637 | $1.01M | 0.0% | -12.8% | 2.884% | |
| 5/11/2022 | GSA Capital Partners LLP | 97,810 | $73K | 0.0% | N/A | 0.210% | |
| 5/6/2022 | Arete Wealth Advisors LLC | 85,000 | $64K | 0.0% | +70.0% | 0.183% | |
| 2/7/2022 | Arete Wealth Advisors LLC | 50,000 | $54K | 0.0% | N/A | 0.128% | |
| 11/15/2021 | Marshall Wace LLP | 258,239 | $0.74M | 0.0% | N/A | 0.675% | |
| 11/12/2021 | Renaissance Technologies LLC | 151,500 | $0.44M | 0.0% | +74.6% | 0.396% | |
| 11/12/2021 | Geode Capital Management LLC | 353,208 | $1.02M | 0.0% | +10.3% | 0.923% | |
| 11/9/2021 | BlackRock Inc. | 98,078 | $0.28M | 0.0% | -9.3% | 0.256% | |
| 9/17/2021 | Virtu Financial LLC | 20,705 | $47K | 0.0% | -48.1% | 0.054% | |
| 8/16/2021 | Schonfeld Strategic Advisors LLC | 23,900 | $54K | 0.0% | -50.1% | 0.062% | |
| 8/16/2021 | Charles Schwab Investment Management Inc. | 22,600 | $52K | 0.0% | N/A | 0.059% | |
| 8/16/2021 | State Street Corp | 101,000 | $0.23M | 0.0% | N/A | 0.264% | |
| 8/13/2021 | Renaissance Technologies LLC | 86,753 | $0.20M | 0.0% | +502.5% | 0.227% | |
| 8/13/2021 | Northern Trust Corp | 72,108 | $0.16M | 0.0% | +71.5% | 0.188% | |
| 8/13/2021 | Sigma Planning Corp | 11,600 | $26K | 0.0% | N/A | 0.030% | |
| 8/13/2021 | Geode Capital Management LLC | 320,333 | $0.73M | 0.0% | +64.3% | 0.837% | |
| 8/13/2021 | Vanguard Group Inc. | 1,381,207 | $3.14M | 0.0% | +7.1% | 3.609% | |
| 8/12/2021 | XTX Topco Ltd | 12,840 | $29K | 0.0% | -26.4% | 0.034% | |
| 8/11/2021 | Susquehanna Fundamental Investments LLC | 51,600 | $0.12M | 0.0% | N/A | 0.135% | |
| 8/10/2021 | National Asset Management Inc. | 11,100 | $26K | 0.0% | -81.4% | 0.029% | |
| 5/21/2021 | Citadel Advisors LLC | 73,277 | $0.18M | 0.0% | N/A | 0.191% | |
| 5/19/2021 | Virtu Financial LLC | 39,877 | $100K | 0.0% | N/A | 0.104% | |
| 5/19/2021 | Squarepoint Ops LLC | 19,979 | $50K | 0.0% | N/A | 0.052% | |
| 5/18/2021 | Private Wealth Advisors | 19,277 | $48K | 0.0% | N/A | 0.050% | |
| 5/18/2021 | Citadel Advisors LLC | 73,277 | $0.18M | 0.0% | N/A | 0.191% | |
| 5/18/2021 | Jane Street Group LLC | 21,964 | $55K | 0.0% | N/A | 0.057% | |
| 5/17/2021 | Schonfeld Strategic Advisors LLC | 47,900 | $0.12M | 0.0% | N/A | 0.125% | |
| 5/17/2021 | HRT Financial LP | 12,316 | $30K | 0.0% | N/A | 0.032% | |
| 5/14/2021 | XTX Topco Ltd | 17,446 | $44K | 0.0% | N/A | 0.046% | |
| 5/13/2021 | Renaissance Technologies LLC | 14,400 | $36K | 0.0% | N/A | 0.038% | |
| 5/13/2021 | Becker Capital Management Inc. | 20,000 | $50K | 0.0% | N/A | 0.052% | |
| 5/12/2021 | Geode Capital Management LLC | 195,024 | $0.49M | 0.0% | +152.1% | 0.510% | |
| 5/7/2021 | BlackRock Inc. | 59,749 | $0.15M | 0.0% | +58.7% | 0.156% | |
| 5/4/2021 | Commonwealth Equity Services LLC | 10,000 | $25K | 0.0% | N/A | 0.026% | |
| 2/12/2021 | Credit Suisse AG | 38,796 | $79K | 0.0% | N/A | 0.173% | |
| 11/19/2020 | Schonfeld Strategic Advisors LLC | 54,000 | $0.11M | 0.0% | N/A | 0.240% | |
| 11/17/2020 | Schonfeld Strategic Advisors LLC | 54,000 | $0.11M | 0.0% | N/A | 0.273% | |
| 10/20/2020 | Wedbush Securities Inc. | 16,500 | $35K | 0.0% | -55.4% | 0.083% | |
| 7/31/2020 | UBS Group AG | 20,651 | $42K | 0.0% | +99.6% | 0.137% | |
| 7/16/2020 | Wedbush Securities Inc. | 37,013 | $76K | 0.0% | N/A | 0.246% | |
| 5/15/2020 | Jane Street Group LLC | 14,316 | $37K | 0.0% | N/A | 0.095% | |
| 5/6/2020 | Bank of New York Mellon Corp | 15,615 | $40K | 0.0% | N/A | 0.131% | |
| 5/1/2020 | UBS Group AG | 10,348 | $26K | 0.0% | N/A | 0.087% | |
| 2/13/2020 | Oxford Asset Management LLP | 23,051 | $26K | 0.0% | N/A | 0.413% | |
| 2/13/2020 | Renaissance Technologies LLC | 68,188 | $77K | 0.0% | +308.5% | 1.222% | |
| 2/4/2020 | Virtu Financial LLC | 53,300 | $60K | 0.0% | N/A | 0.955% | |
| 8/16/2019 | Susquehanna International Group LLP | 71,942 | $28K | 0.0% | N/A | 0.408% | |
| 4/12/2019 | Virtu Financial LLC | 115,918 | $70K | 0.0% | N/A | 1.341% | |
| 2/11/2019 | Bank of New York Mellon Corp | 20,688 | $27K | 0.0% | N/A | 0.239% | |
| 11/19/2018 | B. Riley Financial Inc. | 50,000 | $0.10M | 0.0% | -63.8% | 0.578% | |
| 8/15/2018 | B. Riley Financial Inc. | 138,000 | $0.25M | 0.1% | N/A | 2.222% | |
| 7/24/2018 | Acadian Asset Management LLC | 58,906 | $0.11M | 0.0% | N/A | 0.988% | |
| 2/15/2018 | Sabby Management LLC | 1,129,867 | $0.21M | 0.0% | -31.9% | 22.965% | |
| 10/31/2017 | Perkins Capital Management Inc. | 1,400,000 | $0.43M | 0.5% | N/A | 2.715% | |
| 8/2/2017 | Versant Venture Management LLC | 2,554,211 | $1.65M | 1.3% | No Change | 9.324% | |
Data available starting January 2016
OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen, as well as Curetis CE-IVD-marked polymerase chain reaction-based SARS-CoV-2 test kits. The company's products also comprise ARES Technology Platform, including ARES reference database on antimicrobial resistance using next generation sequencing technology and artificial intelligence powered bioinformatics solutions for antibiotic response prediction; and Unyvero Platform, an automated sample-to-answer molecular diagnostics platform that integrates automated sample preparation, analysis, and identification of disease relevant pathogens and antibiotic resistance markers. The company utilizes molecular diagnostics and informatics to help combat infectious diseases. It also helps clinicians with information about life threatening infections to enhance patient outcomes, and to decrease the spread of infections caused by multidrug-resistant microorganisms. OpGen, Inc. has a collaboration with the New York State Department of Health and ILÚM Health Solutions, LLC to develop a research program to detect, track, and manage antimicrobial-resistant infections at healthcare institutions. The company was incorporated in 2001 and is headquartered in Rockville, Maryland.
Read More on OpGen
Volume
112,976 shs
Average Volume
388,033 shs
Market Capitalization
$26.64 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
Who are the company insiders with the largest holdings of OpGen?
